Eleven Biotherapeutics Raises $35 Million
Eleven Biotherapeutics, a Cambridge, Mass.-based developer of protein-based therapeutics, has raised $35 million in Series A funding. Flagship Ventures and Third Rock Ventures co-led the round.
17 February 2010•4 mins read
